To B or not to B, that is the question: the role of bleomycin in early stage Hodgkin lymphoma

Key Points

• The research focuses on the impact of bleomycin in treating early stage Hodgkin lymphoma.
• Examined the role of bleomycin in treatment regimens.
• Analyzed clinical outcomes of patients with early stage Hodgkin lymphoma.
• Bleomycin may improve treatment responses in patients with early stage Hodgkin lymphoma.